Geftinat 250mg Tablet 30s

Introduction to Geftinat 250mg Tablet 30s

Geftinat 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients with certain gene mutations called EGFR mutations. This medicine is often prescribed to patients who have not undergone chemotherapy before.

Composition of Geftinat 250mg Tablet 30s

The active ingredient in Geftinat 250mg Tablet is Gefitinib, which is an EGFR tyrosine kinase inhibitor. This means it targets and blocks specific proteins that promote the growth of cancer cells.

Uses of Geftinat 250mg Tablet 30s

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Specifically targets cancer with EGFR mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Geftinat 250mg Tablet 30s

Common Side Effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious Side Effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Geftinat 250mg Tablet 30s

Geftinat should not be used by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or allergies to Gefitinib or its ingredients.

How to Take Geftinat 250mg Tablet 30s

• Take one tablet orally once daily.
• Consume at the same time each day for consistency.
• Follow your doctor's instructions regarding dosage and duration.

Conclusion of Geftinat 250mg Tablet 30s

Geftinat 250mg Tablet is a targeted therapy for treating non-small cell lung cancer with specific gene mutations. While it offers significant benefits, it is essential to be aware of its side effects and take necessary precautions. Always consult with your healthcare provider for personalized advice and treatment plans.